NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-121815

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedHomocystinuria, described as the following cases; cystathionine beta-synthase deficiency(CBS), 5,10-methylenetetrahydrofolate reductase deficiency, defects in cobalamin metabolism
Date of first enrollment28/5/2012
Target sample size8
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : RM-003 Dosage And administration of the intervention : Two times a day, oral administration Control intervention name : null

Outcome(s)

Primary OutcomePlasma total homocysteine levels at the end of the treatment
Secondary OutcomePlasma total homocysteine levels at each visit of the treatment Plasma homocystine levels at the end of the treatment

Key inclusion & exclusion criteria

Age minimum
Age maximum
GenderBOTH
Include criteriaHomocystinuria, described as the following cases - cystathionine beta-synthase deficiency(CBS) - 5,10-methylenetetrahydrofolate reductase deficiency - defects in cobalamin metabolism
Exclude criteria

Related Information

Contact

public contact
Name ReqMed Company, Ltd. Pharmaceutical & Business Development
Address betaine@reqmed.co.jp
Telephone
E-mail
Affiliation
scientific contact
Name ReqMed Company, Ltd. Pharmaceutical & Business Development
Address Pharmaceutical & Business Development
Telephone
E-mail
Affiliation